FDA Approved: EUCRISA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for EUCRISA (crisaborole) submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

SUPPL AP for EUCRISA (CRISABOROLE)